Advertisement
Australia markets closed

  • ALL ORDS

    7,862.30
    -147.10 (-1.84%)
     

  • AUD/USD

    0.6407
    -0.0038 (-0.59%)
     

  • ASX 200

    7,612.50
    -140.00 (-1.81%)
     

  • OIL

    85.28
    -0.13 (-0.15%)
     

  • GOLD

    2,390.40
    +7.40 (+0.31%)
     

  • Bitcoin AUD

    98,601.86
    -4,816.38 (-4.66%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

Cocrystal Pharma to Present at the Dawson James Securities 2022 Small Cap Growth Conference

Cocrystal Pharma, Inc.
·1-min read
Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc.

BOTHELL, Wash., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that James Martin, CFO and interim co-CEO, will present a company overview at the Dawson James Securities 2022 Small Cap Growth Conference on Wednesday, October 12, 2022 at 1:00 p.m. Eastern time (10:00 a.m. Pacific time). The conference is being held at the Wyndham Grand Hotel in Jupiter, Fla.

Mr. Martin is available throughout the conference for one-on-one meetings. The Cocrystal presentation will be posted to the IR Calendar of the Company’s website beginning October 12.

About Cocrystal Pharma, Inc.
Cocrystal Pharma, Inc. is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication process of influenza viruses, coronaviruses (including SARS-CoV-2), hepatitis C viruses and noroviruses. Cocrystal employs unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs. For further information about Cocrystal, please visit www.cocrystalpharma.com.

Investor Contact:
LHA Investor Relations
Jody Cain
310-691-7100
jcain@lhai.com

Media Contact:
JQA Partners
Jules Abraham
917-885-7378
Jabraham@jqapartners.com

# # #